CIK 0001641281 · <br>Emerging growth company
Bolt Biotherapeutics, Inc.
Sign in to watch- Ticker
- BOLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472804636
- Phone
- 650-665-9295
- Business address
- 900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Bolt Therapeutics, Inc.
- 8-K Event Other events
- 8-K Event Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Senior VP, Finance and PAO bought 5,000 shares at an average $0.57 ($2,835)
- 4 Open-market buy President, CEO and CFO bought 5,000 shares at an average $0.57 ($2,835)
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 8-K Event Bylaws or fiscal year change
- PRE 14A Proxy Proxy Statement (Preliminary)
- DEF 14A Proxy Proxy Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Delisting notice
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
Page 4 of 15 · 299 filings